BioMarin Pharmaceutical
BMRN
#1449
Rank
HK$94.11 B
Marketcap
HK$493.83
Share price
1.42%
Change (1 day)
-27.60%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2024 (TTM): HK$3.05 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are HK$2.75 Billion. In 2023 the company made an earning of HK$1.46 Billion, an increase over its 2022 earnings that were of HK$1.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) HK$3.05 B108.09%
2023 HK$1.46 B26.07%
2022 HK$1.16 B-298.51%
2021 -HK$0.59 Billion78.04%
2020 -HK$0.33 Billion-55.36%
2019 -HK$0.74 Billion-33.56%
2018 -HK$1.12 Billion297.78%
2017 -HK$0.28 Billion-95.68%
2016 -HK$6.47 Billion437.12%
2015 -HK$1.21 Billion23.91%
2014 -HK$0.98 Billion-29.25%
2013 -HK$1.38 Billion49.23%
2012 -HK$0.93 Billion171.11%
2011 -HK$0.34 Billion103.01%
2010 -HK$0.17 Billion-3903.54%
2009 HK$4.39 M-98.31%
2008 HK$0.26 B-189.7%
2007 -HK$0.3 Billion51.02%
2006 -HK$0.2 Billion-61.58%
2005 -HK$0.5 Billion-56.59%
2004 -HK$1.16 Billion95.13%
2003 -HK$0.59 Billion12.09%
2002 -HK$0.53 Billion73.19%
2001 -HK$0.31 Billion18.32%
2000 -HK$0.26 Billion19.65%
1999 -HK$0.22 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$4.05 Billion-232.85%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$1.61 Billion-152.74%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$0.32 Billion-110.40%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$57.65 B 1,792.41%๐Ÿ‡ซ๐Ÿ‡ท France
-HK$0.78 Billion-125.51%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.72 B-76.10%๐Ÿ‡บ๐Ÿ‡ธ USA